tiprankstipranks
Trending News
More News >
OCI N.V. (NL:OCI)
:OCI
Advertisement

OCI N.V. (OCI) AI Stock Analysis

Compare
12 Followers

Top Page

NL:OCI

OCI N.V.

(LSE:OCI)

Rating:53Neutral
Price Target:
€7.50
▲(50.91% Upside)
OCI N.V.'s overall stock score is primarily influenced by its financial performance and technical analysis. The financial performance indicates variability and challenges in profitability and cash management, while technical analysis shows a neutral to slightly positive trend. Valuation metrics suggest caution due to a negative P/E ratio and an unsustainably high dividend yield. The absence of earnings call and corporate events data limits further insights.

OCI N.V. (OCI) vs. iShares MSCI Netherlands ETF (EWN)

OCI N.V. Business Overview & Revenue Model

Company DescriptionOCI N.V. produces and distributes natural gas-based products and industrial chemicals to agricultural, transportation, and industrial customers. It operates through Methanol US, Methanol Europe, Nitrogen US, Nitrogen Europe, and Fertiglobe segments. The company offers anhydrous ammonia, granular urea, urea ammonium nitrate solution, calcium ammonium nitrate, ammonium sulphate, nitrogen argon, aqueous ammonia, nitric acid, urea solution, bio-methanol, methanol, melamine, and diesel exhaust fluid, as well as and other nitrogen products. It also owns and operates an ammonia export terminal at the port of Rotterdam. The company has operations in Europe, the Americas, the Middle East, Africa, Asia, and Oceania. OCI N.V. has a strategic partnership with Abu Dhabi National Oil Company. OCI N.V. was founded in 2013 and is headquartered in Amsterdam, the Netherlands.
How the Company Makes MoneyOCI generates revenue primarily through the sale of nitrogen fertilizers and industrial chemicals. The company produces a range of products, including urea, ammonium nitrate, and ammonia, which are sold to agricultural and industrial customers worldwide. Key revenue streams come from both the agricultural segment, where fertilizers are sold to farmers and distributors, and the industrial segment, where chemicals are supplied to manufacturers across various industries. OCI also benefits from strategic partnerships and long-term contracts with key clients, ensuring a steady demand for its products. Additionally, fluctuations in raw material prices and global agricultural demand can significantly impact the company's earnings, making them sensitive to market conditions.

OCI N.V. Financial Statement Overview

Summary
OCI N.V. has shown significant variability in financial performance. The income statement reflects volatility with a notable decline in gross profit margin and negative EBIT and EBITDA margins. The balance sheet indicates improved leverage but remains moderate overall. Cash flow instability is evident with a reversal from positive to negative free cash flow.
Income Statement
45
Neutral
OCI N.V. has shown volatility in its income statement metrics. The gross profit margin fluctuated significantly, with a notable decline in 2023. Net profit margin improved dramatically in 2024, following a negative figure in the previous year. Revenue growth was negative from 2023 to 2024, indicating a revenue decline. The EBIT and EBITDA margins were negative for the last two years, suggesting challenges in operational efficiency.
Balance Sheet
60
Neutral
The balance sheet shows a moderate financial position. The debt-to-equity ratio improved from 2023 to 2024, indicating reduced leverage. However, the ROE was negative in 2023, but has seen a turnaround in 2024 with a positive net income. The equity ratio remains stable, highlighting a consistent equity base relative to total assets.
Cash Flow
55
Neutral
OCI N.V.'s cash flow metrics depict instability. The free cash flow turned negative in 2024, reversing from a positive flow in 2023. The operating cash flow to net income ratio was strong in 2024, despite previous inconsistencies. The free cash flow to net income ratio in 2024 was negative due to negative free cash flow.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue975.10M1.96B9.71B6.32B3.47B
Gross Profit2.00M-164.60M3.35B1.83B412.10M
EBITDA38.90M-144.00M565.30M2.47B798.80M
Net Income4.98B-392.00M2.43B1.16B-94.10M
Balance Sheet
Total Assets4.33B8.97B9.77B9.81B9.10B
Cash, Cash Equivalents and Short-Term Investments2.05B156.90M1.69B1.44B632.20M
Total Debt803.70M2.30B3.15B4.08B4.71B
Total Liabilities2.08B7.02B5.43B6.30B6.43B
Stockholders Equity2.24B926.50M2.32B2.00B1.13B
Cash Flow
Free Cash Flow-8.20M151.10M2.95B2.02B354.60M
Operating Cash Flow68.10M695.30M3.35B2.26B617.80M
Investing Cash Flow8.07B-774.30M-390.80M-243.50M-260.20M
Financing Cash Flow-6.13B-818.20M-2.44B-1.50B-244.90M

OCI N.V. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price4.97
Price Trends
50DMA
4.79
Positive
100DMA
4.68
Positive
200DMA
4.43
Positive
Market Momentum
MACD
0.07
Negative
RSI
58.81
Neutral
STOCH
7.08
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NL:OCI, the sentiment is Positive. The current price of 4.97 is above the 20-day moving average (MA) of 4.80, above the 50-day MA of 4.79, and above the 200-day MA of 4.43, indicating a bullish trend. The MACD of 0.07 indicates Negative momentum. The RSI at 58.81 is Neutral, neither overbought nor oversold. The STOCH value of 7.08 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NL:OCI.

OCI N.V. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$10.31B6.160.76%2.94%3.30%-36.34%
53
Neutral
€1.05B58.27
57.02%
€10.27B25.079.60%
€776.04M84.951.94%
€1.87B10.055.98%
€1.01B15.058.84%
€5.60B20.6614.32%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NL:OCI
OCI N.V.
4.97
0.43
9.54%
GB:0A00
Akzo Nobel NV
60.37
5.73
10.49%
GB:0LO9
AMG ADVANCED METALLURGICAL GROUP NV
25.82
10.97
73.87%
GB:0OLF
Aperam S.A.
26.36
2.46
10.29%
GB:0QHL
Corbion NV
17.49
-3.29
-15.83%
GB:0QVU
IMCD N.V.
94.64
-48.35
-33.81%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 12, 2025